» Articles » PMID: 36688097

Aptamer-based Rapid Diagnosis for Point-of-care Application

Overview
Publisher Springer
Date 2023 Jan 23
PMID 36688097
Authors
Affiliations
Soon will be listed here.
Abstract

Aptasensors have attracted considerable interest and widespread application in point-of-care testing worldwide. One of the biggest challenges of a point-of-care (POC) is the reduction of treatment time compared to central facilities that diagnose and monitor the applications. Over the past decades, biosensors have been introduced that offer more reliable, cost-effective, and accurate detection methods. Aptamer-based biosensors have unprecedented advantages over biosensors that use natural receptors such as antibodies and enzymes. In the current epidemic, point-of-care testing (POCT) is advantageous because it is easy to use, more accessible, faster to detect, and has high accuracy and sensitivity, reducing the burden of testing on healthcare systems. POCT is beneficial for daily epidemic control as well as early detection and treatment. This review provides detailed information on the various design strategies and virus detection methods using aptamer-based sensors. In addition, we discussed the importance of different aptamers and their detection principles. Aptasensors with higher sensitivity, specificity, and flexibility are critically discussed to establish simple, cost-effective, and rapid detection methods. POC-based aptasensors' diagnostic applications are classified and summarised based on infectious and infectious diseases. Finally, the design factors to be considered are outlined to meet the future of rapid POC-based sensors.

Citing Articles

Recent Advances in Aptamers-Based Nanosystems for Diagnosis and Therapy of Cardiovascular Diseases: An Updated Review.

Yu H, Yu J, Yao G Int J Nanomedicine. 2025; 20:2427-2443.

PMID: 40034222 PMC: 11873322. DOI: 10.2147/IJN.S507715.


AI-optimized electrochemical aptasensors for stable, reproducible detection of neurodegenerative diseases, cancer, and coronavirus.

Tayfour Ahmed A, Dhahi T, Attia T, Elhassan Ali F, Elobaid M, Adam T Heliyon. 2025; 11(1):e41338.

PMID: 39834418 PMC: 11742820. DOI: 10.1016/j.heliyon.2024.e41338.


Recent advances in nanomaterials for the detection of mycobacterium tuberculosis (Review).

Zhu J, Wang H, Chen L Int J Mol Med. 2024; 55(3.

PMID: 39717951 PMC: 11722055. DOI: 10.3892/ijmm.2024.5477.


Recent Developments in Aptamer-Based Sensors for Diagnostics.

Sheraz M, Sun X, Wang Y, Chen J, Sun L Sensors (Basel). 2024; 24(23).

PMID: 39685966 PMC: 11644826. DOI: 10.3390/s24237432.


Comparative Analysis of QCM and Electrochemical Aptasensors for SARS-CoV-2 Detection.

Nemcekova K, Korcekova J, Svitkova V, Baraniak D, Domsicova M, Melnikova E Biosensors (Basel). 2024; 14(9).

PMID: 39329806 PMC: 11429642. DOI: 10.3390/bios14090431.


References
1.
Wang R, Li Y . Hydrogel based QCM aptasensor for detection of avian influenza virus. Biosens Bioelectron. 2012; 42:148-55. DOI: 10.1016/j.bios.2012.10.038. View

2.
Park J, Lee S, Choi E, Kim J, Song J, Gu M . An ultra-sensitive detection of a whole virus using dual aptamers developed by immobilization-free screening. Biosens Bioelectron. 2013; 51:324-9. DOI: 10.1016/j.bios.2013.07.052. View

3.
Wang X, Dong P, He P, Fang Y . A solid-state electrochemiluminescence sensing platform for detection of adenosine based on ferrocene-labeled structure-switching signaling aptamer. Anal Chim Acta. 2010; 658(2):128-32. DOI: 10.1016/j.aca.2009.11.007. View

4.
He M, Shang N, Zhu Q, Xu J . Paper-based upconversion fluorescence aptasensor for the quantitative detection of immunoglobulin E in human serum. Anal Chim Acta. 2021; 1143:93-100. DOI: 10.1016/j.aca.2020.11.036. View

5.
John A, Price C . Existing and Emerging Technologies for Point-of-Care Testing. Clin Biochem Rev. 2014; 35(3):155-67. PMC: 4204237. View